nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—migraine—Prednisone—systemic scleroderma	0.835	1	CpDpCtD
Methylergometrine—HTR2B—cardial valve—systemic scleroderma	0.0232	0.474	CbGeAlD
Methylergometrine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.00707	0.145	CbGeAlD
Methylergometrine—Acute myocardial infarction—Lisinopril—systemic scleroderma	0.00632	0.0545	CcSEcCtD
Methylergometrine—HTR2A—pulmonary artery—systemic scleroderma	0.00501	0.103	CbGeAlD
Methylergometrine—Vasospasm—Mycophenolic acid—systemic scleroderma	0.00375	0.0324	CcSEcCtD
Methylergometrine—Vasospasm—Mycophenolate mofetil—systemic scleroderma	0.00296	0.0255	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Pentoxifylline—systemic scleroderma	0.00198	0.017	CcSEcCtD
Methylergometrine—HTR2A—artery—systemic scleroderma	0.00186	0.038	CbGeAlD
Methylergometrine—Nasal congestion—Pentoxifylline—systemic scleroderma	0.00171	0.0148	CcSEcCtD
Methylergometrine—HTR2A—endothelium—systemic scleroderma	0.00157	0.0321	CbGeAlD
Methylergometrine—Ventricular fibrillation—Lisinopril—systemic scleroderma	0.00151	0.013	CcSEcCtD
Methylergometrine—Nasal congestion—Mometasone—systemic scleroderma	0.00148	0.0128	CcSEcCtD
Methylergometrine—HTR2A—blood vessel—systemic scleroderma	0.00145	0.0296	CbGeAlD
Methylergometrine—Angina pectoris—Pentoxifylline—systemic scleroderma	0.00132	0.0113	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Mycophenolic acid—systemic scleroderma	0.00128	0.0111	CcSEcCtD
Methylergometrine—HTR2B—smooth muscle tissue—systemic scleroderma	0.00127	0.026	CbGeAlD
Methylergometrine—HTR2B—skin of body—systemic scleroderma	0.00125	0.0257	CbGeAlD
Methylergometrine—Cramps of lower extremities—Leflunomide—systemic scleroderma	0.00123	0.0106	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Captopril—systemic scleroderma	0.00121	0.0104	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Mycophenolic acid—systemic scleroderma	0.00118	0.0102	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Lisinopril—systemic scleroderma	0.00115	0.00996	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00873	CcSEcCtD
Methylergometrine—HTR2B—digestive system—systemic scleroderma	0.001	0.0205	CbGeAlD
Methylergometrine—Angina pectoris—Captopril—systemic scleroderma	0.000997	0.0086	CcSEcCtD
Methylergometrine—HTR2B—tendon—systemic scleroderma	0.000954	0.0195	CbGeAlD
Methylergometrine—Cramps of lower extremities—Mycophenolate mofetil—systemic scleroderma	0.00093	0.00802	CcSEcCtD
Methylergometrine—Nasal congestion—Lisinopril—systemic scleroderma	0.00092	0.00794	CcSEcCtD
Methylergometrine—Muscle spasms—Pentoxifylline—systemic scleroderma	0.000904	0.0078	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Lisinopril—systemic scleroderma	0.000855	0.00738	CcSEcCtD
Methylergometrine—Thrombophlebitis—Mycophenolate mofetil—systemic scleroderma	0.000849	0.00732	CcSEcCtD
Methylergometrine—HTR2B—lung—systemic scleroderma	0.000837	0.0171	CbGeAlD
Methylergometrine—Palpitations—Pentoxifylline—systemic scleroderma	0.000831	0.00717	CcSEcCtD
Methylergometrine—Sweating increased—Leflunomide—systemic scleroderma	0.000821	0.00708	CcSEcCtD
Methylergometrine—Angina pectoris—Leflunomide—systemic scleroderma	0.000821	0.00708	CcSEcCtD
Methylergometrine—Convulsion—Pentoxifylline—systemic scleroderma	0.000815	0.00703	CcSEcCtD
Methylergometrine—Hallucination—Captopril—systemic scleroderma	0.000815	0.00703	CcSEcCtD
Methylergometrine—Hypertension—Pentoxifylline—systemic scleroderma	0.000812	0.007	CcSEcCtD
Methylergometrine—Chest pain—Pentoxifylline—systemic scleroderma	0.000801	0.00691	CcSEcCtD
Methylergometrine—Angina pectoris—Mycophenolic acid—systemic scleroderma	0.000784	0.00676	CcSEcCtD
Methylergometrine—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.000768	0.00662	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Mycophenolate mofetil—systemic scleroderma	0.00075	0.00646	CcSEcCtD
Methylergometrine—Tachycardia—Pentoxifylline—systemic scleroderma	0.000749	0.00646	CcSEcCtD
Methylergometrine—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.000742	0.0064	CcSEcCtD
Methylergometrine—HTR2A—connective tissue—systemic scleroderma	0.000741	0.0152	CbGeAlD
Methylergometrine—Hypotension—Pentoxifylline—systemic scleroderma	0.000717	0.00619	CcSEcCtD
Methylergometrine—Haematuria—Leflunomide—systemic scleroderma	0.000717	0.00618	CcSEcCtD
Methylergometrine—Sweating increased—Lisinopril—systemic scleroderma	0.000706	0.00609	CcSEcCtD
Methylergometrine—Angina pectoris—Lisinopril—systemic scleroderma	0.000706	0.00609	CcSEcCtD
Methylergometrine—Chest pain—Mometasone—systemic scleroderma	0.000691	0.00596	CcSEcCtD
Methylergometrine—Dyspnoea—Pentoxifylline—systemic scleroderma	0.000684	0.0059	CcSEcCtD
Methylergometrine—Haematuria—Mycophenolic acid—systemic scleroderma	0.000684	0.0059	CcSEcCtD
Methylergometrine—HTR2A—smooth muscle tissue—systemic scleroderma	0.000678	0.0139	CbGeAlD
Methylergometrine—Anaphylactic shock—Mometasone—systemic scleroderma	0.000662	0.00571	CcSEcCtD
Methylergometrine—Bradycardia—Mycophenolic acid—systemic scleroderma	0.000655	0.00565	CcSEcCtD
Methylergometrine—Hallucination—Mycophenolic acid—systemic scleroderma	0.000641	0.00553	CcSEcCtD
Methylergometrine—Palpitations—Captopril—systemic scleroderma	0.00063	0.00543	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.000628	0.00541	CcSEcCtD
Methylergometrine—Cardiac disorder—Leflunomide—systemic scleroderma	0.000626	0.0054	CcSEcCtD
Methylergometrine—Angina pectoris—Mycophenolate mofetil—systemic scleroderma	0.000618	0.00533	CcSEcCtD
Methylergometrine—Haematuria—Lisinopril—systemic scleroderma	0.000616	0.00531	CcSEcCtD
Methylergometrine—Chest pain—Captopril—systemic scleroderma	0.000607	0.00523	CcSEcCtD
Methylergometrine—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000607	0.00523	CcSEcCtD
Methylergometrine—Tinnitus—Mycophenolic acid—systemic scleroderma	0.0006	0.00518	CcSEcCtD
Methylergometrine—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.000598	0.00515	CcSEcCtD
Methylergometrine—Paraesthesia—Mometasone—systemic scleroderma	0.000595	0.00513	CcSEcCtD
Methylergometrine—Dyspnoea—Mometasone—systemic scleroderma	0.000591	0.00509	CcSEcCtD
Methylergometrine—Bradycardia—Lisinopril—systemic scleroderma	0.00059	0.00509	CcSEcCtD
Methylergometrine—Anaphylactic shock—Captopril—systemic scleroderma	0.000582	0.00502	CcSEcCtD
Methylergometrine—Hallucination—Lisinopril—systemic scleroderma	0.000577	0.00498	CcSEcCtD
Methylergometrine—Thrombophlebitis—Prednisone—systemic scleroderma	0.000575	0.00496	CcSEcCtD
Methylergometrine—Tachycardia—Captopril—systemic scleroderma	0.000568	0.0049	CcSEcCtD
Methylergometrine—Muscle spasms—Leflunomide—systemic scleroderma	0.000565	0.00487	CcSEcCtD
Methylergometrine—Hypotension—Captopril—systemic scleroderma	0.000544	0.00469	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000542	0.00467	CcSEcCtD
Methylergometrine—Tinnitus—Lisinopril—systemic scleroderma	0.000541	0.00466	CcSEcCtD
Methylergometrine—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.00054	0.00465	CcSEcCtD
Methylergometrine—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.000539	0.00465	CcSEcCtD
Methylergometrine—HTR2A—digestive system—systemic scleroderma	0.000535	0.011	CbGeAlD
Methylergometrine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000525	0.00453	CcSEcCtD
Methylergometrine—Abdominal pain—Mometasone—systemic scleroderma	0.000524	0.00452	CcSEcCtD
Methylergometrine—Paraesthesia—Captopril—systemic scleroderma	0.000522	0.00451	CcSEcCtD
Methylergometrine—Palpitations—Leflunomide—systemic scleroderma	0.000519	0.00448	CcSEcCtD
Methylergometrine—Dyspnoea—Captopril—systemic scleroderma	0.000519	0.00447	CcSEcCtD
Methylergometrine—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.000517	0.00446	CcSEcCtD
Methylergometrine—HTR2A—tendon—systemic scleroderma	0.00051	0.0104	CbGeAlD
Methylergometrine—Dizziness—Pentoxifylline—systemic scleroderma	0.000508	0.00438	CcSEcCtD
Methylergometrine—Hypertension—Leflunomide—systemic scleroderma	0.000507	0.00437	CcSEcCtD
Methylergometrine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000506	0.00436	CcSEcCtD
Methylergometrine—Chest pain—Leflunomide—systemic scleroderma	0.0005	0.00431	CcSEcCtD
Methylergometrine—CYP3A4—digestive system—systemic scleroderma	0.000496	0.0102	CbGeAlD
Methylergometrine—Palpitations—Mycophenolic acid—systemic scleroderma	0.000495	0.00427	CcSEcCtD
Methylergometrine—Vomiting—Pentoxifylline—systemic scleroderma	0.000488	0.00421	CcSEcCtD
Methylergometrine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000486	0.00419	CcSEcCtD
Methylergometrine—Muscle spasms—Lisinopril—systemic scleroderma	0.000485	0.00419	CcSEcCtD
Methylergometrine—Rash—Pentoxifylline—systemic scleroderma	0.000484	0.00417	CcSEcCtD
Methylergometrine—Hypertension—Mycophenolic acid—systemic scleroderma	0.000484	0.00417	CcSEcCtD
Methylergometrine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000484	0.00417	CcSEcCtD
Methylergometrine—Headache—Pentoxifylline—systemic scleroderma	0.000481	0.00415	CcSEcCtD
Methylergometrine—Thrombophlebitis—Methotrexate—systemic scleroderma	0.000481	0.00415	CcSEcCtD
Methylergometrine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00048	0.00414	CcSEcCtD
Methylergometrine—Chest pain—Mycophenolic acid—systemic scleroderma	0.000477	0.00412	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000476	0.0041	CcSEcCtD
Methylergometrine—Hypotension—Azathioprine—systemic scleroderma	0.000474	0.00409	CcSEcCtD
Methylergometrine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000474	0.00409	CcSEcCtD
Methylergometrine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000472	0.00407	CcSEcCtD
Methylergometrine—Nervous system disorder—Leflunomide—systemic scleroderma	0.00047	0.00406	CcSEcCtD
Methylergometrine—Tachycardia—Leflunomide—systemic scleroderma	0.000468	0.00404	CcSEcCtD
Methylergometrine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000464	0.004	CcSEcCtD
Methylergometrine—Abdominal pain—Captopril—systemic scleroderma	0.00046	0.00397	CcSEcCtD
Methylergometrine—Nausea—Pentoxifylline—systemic scleroderma	0.000456	0.00393	CcSEcCtD
Methylergometrine—Diarrhoea—Mometasone—systemic scleroderma	0.000453	0.00391	CcSEcCtD
Methylergometrine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000449	0.00387	CcSEcCtD
Methylergometrine—Hypotension—Leflunomide—systemic scleroderma	0.000448	0.00386	CcSEcCtD
Methylergometrine—HTR2A—lung—systemic scleroderma	0.000447	0.00916	CbGeAlD
Methylergometrine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000446	0.00385	CcSEcCtD
Methylergometrine—Palpitations—Lisinopril—systemic scleroderma	0.000446	0.00385	CcSEcCtD
Methylergometrine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000442	0.00381	CcSEcCtD
Methylergometrine—Paraesthesia—Leflunomide—systemic scleroderma	0.000431	0.00371	CcSEcCtD
Methylergometrine—Chest pain—Lisinopril—systemic scleroderma	0.00043	0.00371	CcSEcCtD
Methylergometrine—Dyspnoea—Leflunomide—systemic scleroderma	0.000428	0.00369	CcSEcCtD
Methylergometrine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000427	0.00369	CcSEcCtD
Methylergometrine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000425	0.00367	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000425	0.00366	CcSEcCtD
Methylergometrine—Vomiting—Mometasone—systemic scleroderma	0.000421	0.00363	CcSEcCtD
Methylergometrine—Sweating increased—Prednisone—systemic scleroderma	0.000419	0.00362	CcSEcCtD
Methylergometrine—Rash—Mometasone—systemic scleroderma	0.000418	0.0036	CcSEcCtD
Methylergometrine—Dermatitis—Mometasone—systemic scleroderma	0.000417	0.0036	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000415	0.00358	CcSEcCtD
Methylergometrine—Headache—Mometasone—systemic scleroderma	0.000415	0.00358	CcSEcCtD
Methylergometrine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000412	0.00355	CcSEcCtD
Methylergometrine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000411	0.00354	CcSEcCtD
Methylergometrine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000408	0.00352	CcSEcCtD
Methylergometrine—Tachycardia—Lisinopril—systemic scleroderma	0.000402	0.00347	CcSEcCtD
Methylergometrine—Abdominal pain—Azathioprine—systemic scleroderma	0.000401	0.00346	CcSEcCtD
Methylergometrine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000398	0.00344	CcSEcCtD
Methylergometrine—Diarrhoea—Captopril—systemic scleroderma	0.000398	0.00343	CcSEcCtD
Methylergometrine—Nausea—Mometasone—systemic scleroderma	0.000393	0.00339	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000392	0.00338	CcSEcCtD
Methylergometrine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000391	0.00337	CcSEcCtD
Methylergometrine—Hypotension—Lisinopril—systemic scleroderma	0.000385	0.00332	CcSEcCtD
Methylergometrine—Dizziness—Captopril—systemic scleroderma	0.000385	0.00332	CcSEcCtD
Methylergometrine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000383	0.00331	CcSEcCtD
Methylergometrine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000382	0.00329	CcSEcCtD
Methylergometrine—Abdominal pain—Leflunomide—systemic scleroderma	0.000379	0.00327	CcSEcCtD
Methylergometrine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000377	0.00325	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000374	0.00323	CcSEcCtD
Methylergometrine—Paraesthesia—Lisinopril—systemic scleroderma	0.00037	0.00319	CcSEcCtD
Methylergometrine—Vomiting—Captopril—systemic scleroderma	0.00037	0.00319	CcSEcCtD
Methylergometrine—Dyspnoea—Lisinopril—systemic scleroderma	0.000367	0.00317	CcSEcCtD
Methylergometrine—Rash—Captopril—systemic scleroderma	0.000367	0.00316	CcSEcCtD
Methylergometrine—Dermatitis—Captopril—systemic scleroderma	0.000367	0.00316	CcSEcCtD
Methylergometrine—Headache—Captopril—systemic scleroderma	0.000364	0.00314	CcSEcCtD
Methylergometrine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000362	0.00312	CcSEcCtD
Methylergometrine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000361	0.00311	CcSEcCtD
Methylergometrine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000354	0.00305	CcSEcCtD
Methylergometrine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000352	0.00304	CcSEcCtD
Methylergometrine—Bradycardia—Prednisone—systemic scleroderma	0.000351	0.00302	CcSEcCtD
Methylergometrine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000349	0.00301	CcSEcCtD
Methylergometrine—Diarrhoea—Azathioprine—systemic scleroderma	0.000347	0.003	CcSEcCtD
Methylergometrine—Nausea—Captopril—systemic scleroderma	0.000346	0.00298	CcSEcCtD
Methylergometrine—Hallucination—Prednisone—systemic scleroderma	0.000343	0.00296	CcSEcCtD
Methylergometrine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000337	0.00291	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000337	0.00291	CcSEcCtD
Methylergometrine—Dizziness—Azathioprine—systemic scleroderma	0.000336	0.0029	CcSEcCtD
Methylergometrine—Diarrhoea—Leflunomide—systemic scleroderma	0.000328	0.00283	CcSEcCtD
Methylergometrine—Abdominal pain—Lisinopril—systemic scleroderma	0.000326	0.00281	CcSEcCtD
Methylergometrine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000324	0.0028	CcSEcCtD
Methylergometrine—Vomiting—Azathioprine—systemic scleroderma	0.000323	0.00278	CcSEcCtD
Methylergometrine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000322	0.00278	CcSEcCtD
Methylergometrine—Rash—Azathioprine—systemic scleroderma	0.00032	0.00276	CcSEcCtD
Methylergometrine—Dermatitis—Azathioprine—systemic scleroderma	0.00032	0.00276	CcSEcCtD
Methylergometrine—Headache—Azathioprine—systemic scleroderma	0.000318	0.00274	CcSEcCtD
Methylergometrine—Dizziness—Leflunomide—systemic scleroderma	0.000317	0.00273	CcSEcCtD
Methylergometrine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000313	0.0027	CcSEcCtD
Methylergometrine—Haematuria—Methotrexate—systemic scleroderma	0.000306	0.00264	CcSEcCtD
Methylergometrine—Vomiting—Leflunomide—systemic scleroderma	0.000305	0.00263	CcSEcCtD
Methylergometrine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000303	0.00261	CcSEcCtD
Methylergometrine—Rash—Leflunomide—systemic scleroderma	0.000302	0.00261	CcSEcCtD
Methylergometrine—Dermatitis—Leflunomide—systemic scleroderma	0.000302	0.00261	CcSEcCtD
Methylergometrine—Nausea—Azathioprine—systemic scleroderma	0.000302	0.0026	CcSEcCtD
Methylergometrine—Headache—Leflunomide—systemic scleroderma	0.0003	0.00259	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000295	0.00255	CcSEcCtD
Methylergometrine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000291	0.00251	CcSEcCtD
Methylergometrine—Rash—Mycophenolic acid—systemic scleroderma	0.000288	0.00249	CcSEcCtD
Methylergometrine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000288	0.00249	CcSEcCtD
Methylergometrine—Headache—Mycophenolic acid—systemic scleroderma	0.000287	0.00247	CcSEcCtD
Methylergometrine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00246	CcSEcCtD
Methylergometrine—Nausea—Leflunomide—systemic scleroderma	0.000285	0.00246	CcSEcCtD
Methylergometrine—Diarrhoea—Lisinopril—systemic scleroderma	0.000282	0.00243	CcSEcCtD
Methylergometrine—Dizziness—Lisinopril—systemic scleroderma	0.000272	0.00235	CcSEcCtD
Methylergometrine—Nausea—Mycophenolic acid—systemic scleroderma	0.000272	0.00234	CcSEcCtD
Methylergometrine—Tinnitus—Methotrexate—systemic scleroderma	0.000268	0.00231	CcSEcCtD
Methylergometrine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000267	0.0023	CcSEcCtD
Methylergometrine—Vomiting—Lisinopril—systemic scleroderma	0.000262	0.00226	CcSEcCtD
Methylergometrine—Rash—Lisinopril—systemic scleroderma	0.00026	0.00224	CcSEcCtD
Methylergometrine—Convulsion—Prednisone—systemic scleroderma	0.00026	0.00224	CcSEcCtD
Methylergometrine—Dermatitis—Lisinopril—systemic scleroderma	0.00026	0.00224	CcSEcCtD
Methylergometrine—Hypertension—Prednisone—systemic scleroderma	0.000259	0.00223	CcSEcCtD
Methylergometrine—Headache—Lisinopril—systemic scleroderma	0.000258	0.00223	CcSEcCtD
Methylergometrine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000247	0.00213	CcSEcCtD
Methylergometrine—Nausea—Lisinopril—systemic scleroderma	0.000245	0.00211	CcSEcCtD
Methylergometrine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000245	0.00211	CcSEcCtD
Methylergometrine—Nervous system disorder—Prednisone—systemic scleroderma	0.00024	0.00207	CcSEcCtD
Methylergometrine—Tachycardia—Prednisone—systemic scleroderma	0.000239	0.00206	CcSEcCtD
Methylergometrine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000239	0.00206	CcSEcCtD
Methylergometrine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000237	0.00204	CcSEcCtD
Methylergometrine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00023	0.00198	CcSEcCtD
Methylergometrine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000228	0.00196	CcSEcCtD
Methylergometrine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000227	0.00196	CcSEcCtD
Methylergometrine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000226	0.00195	CcSEcCtD
Methylergometrine—Paraesthesia—Prednisone—systemic scleroderma	0.00022	0.0019	CcSEcCtD
Methylergometrine—Convulsion—Methotrexate—systemic scleroderma	0.000217	0.00187	CcSEcCtD
Methylergometrine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000214	0.00185	CcSEcCtD
Methylergometrine—Chest pain—Methotrexate—systemic scleroderma	0.000213	0.00184	CcSEcCtD
Methylergometrine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000205	0.00176	CcSEcCtD
Methylergometrine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000201	0.00173	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.0002	0.00173	CcSEcCtD
Methylergometrine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000198	0.00171	CcSEcCtD
Methylergometrine—Abdominal pain—Prednisone—systemic scleroderma	0.000193	0.00167	CcSEcCtD
Methylergometrine—Hypotension—Methotrexate—systemic scleroderma	0.000191	0.00165	CcSEcCtD
Methylergometrine—Paraesthesia—Methotrexate—systemic scleroderma	0.000184	0.00158	CcSEcCtD
Methylergometrine—Dyspnoea—Methotrexate—systemic scleroderma	0.000182	0.00157	CcSEcCtD
Methylergometrine—Diarrhoea—Prednisone—systemic scleroderma	0.000167	0.00144	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000167	0.00144	CcSEcCtD
Methylergometrine—Dizziness—Prednisone—systemic scleroderma	0.000162	0.0014	CcSEcCtD
Methylergometrine—Abdominal pain—Methotrexate—systemic scleroderma	0.000162	0.00139	CcSEcCtD
Methylergometrine—Vomiting—Prednisone—systemic scleroderma	0.000156	0.00134	CcSEcCtD
Methylergometrine—Rash—Prednisone—systemic scleroderma	0.000154	0.00133	CcSEcCtD
Methylergometrine—Dermatitis—Prednisone—systemic scleroderma	0.000154	0.00133	CcSEcCtD
Methylergometrine—Headache—Prednisone—systemic scleroderma	0.000153	0.00132	CcSEcCtD
Methylergometrine—Nausea—Prednisone—systemic scleroderma	0.000145	0.00125	CcSEcCtD
Methylergometrine—Diarrhoea—Methotrexate—systemic scleroderma	0.00014	0.00121	CcSEcCtD
Methylergometrine—Dizziness—Methotrexate—systemic scleroderma	0.000135	0.00117	CcSEcCtD
Methylergometrine—Vomiting—Methotrexate—systemic scleroderma	0.00013	0.00112	CcSEcCtD
Methylergometrine—Rash—Methotrexate—systemic scleroderma	0.000129	0.00111	CcSEcCtD
Methylergometrine—Dermatitis—Methotrexate—systemic scleroderma	0.000129	0.00111	CcSEcCtD
Methylergometrine—Headache—Methotrexate—systemic scleroderma	0.000128	0.0011	CcSEcCtD
Methylergometrine—Nausea—Methotrexate—systemic scleroderma	0.000121	0.00105	CcSEcCtD
